Detalhe da pesquisa
1.
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Blood
; 127(24): 3004-14, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26966091
2.
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Oncologist
; 21(1): 33-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26670666
3.
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
J Transl Med
; 14(1): 339, 2016 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27974047
4.
Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Oncologist
; 20(1): 7-12, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480824
5.
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Oncologist
; 20(5): 499-507, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882375
6.
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
Breast Cancer Res Treat
; 154(1): 155-62, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26458824
7.
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Oncologist
; 19(3): 235-42, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24563076
8.
Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets.
Br J Haematol
; 178(4): 640-642, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27291498
9.
Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant.
Cold Spring Harb Mol Case Stud
; 3(5)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550065
10.
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.
Cancer Discov
; 6(6): 594-600, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27048246
11.
Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Oncotarget
; 7(48): 78226-78241, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793025
12.
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.
Cancer Discov
; 6(6): 601-11, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102076
13.
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
JAMA Oncol
; 1(1): 40-49, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26182302
14.
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.
Cancer Discov
; 5(10): 1049-57, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216294
15.
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.
Onco Targets Ther
; 8: 3561-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26664139
16.
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Arch Pathol Lab Med
; 139(5): 642-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25927147
17.
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Cancer Discov
; 5(8): 850-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25971938
18.
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.
Case Rep Oncol
; 7(2): 503-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25232318
19.
Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.
Cancer Res
; 71(21): 6601-10, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21920898
20.
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition.
Clin Cancer Res
; 17(11): 3706-15, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482692